Aaron Lee Berez

ABK Biomedical, Inc. develops embolotherapeutic products for the treatment of uterine fibroids. It engages in the development, production and sale of embolic agents and peripheral vascular delivery devices. The company was founded by Bob Abraham, Daniel Boyd and Sharon Kehoe in 2012 and is headquartered in Halifax, Canada.

Companion Medical, Inc. develops solutions for diabetes management called InPen. The company was founded by Sean Saint in 2013 and is headquartered in San Diego, CA.

Palmera Medical, Inc. provides technology support services. The company is headquartered in Mountain View, CA.

CalCanada Biomed Fund LLC engages in investment activities. The company was founded in 2006 and is headquartered in Mountain View, CA.

CorVista Health, Inc. develops medical imaging solutions. It offers Agilytics, a machine intelligence technology platform that analyzes phase space tomography data to identify and assess specific disease. The company is headquartered in Toronto, Canada.

Avails Medical, Inc. is an in-vitro diagnostics company. The company was founded by Oren Knopfmacher, Meike Herget, Naama Stauber, Robert Fisher, and Nancy Isaac in 2013 and is headquartered in Menlo Park, CA.

Alembic LLC is a privately held American medical device incubator company founded in 2012 by Dr. Aaron Berez. The company focuses on bringing novel neurovascular solutions to market. Its first portfolio company, Cathera, Inc, developed the Phenom family of microcatheters optimized for intracranial navigation. The company has a strong manufacturing foundation focused on continuous quality improvement, and its products are shipped worldwide and used in interventional lifesaving procedures around the world. Alembic brings novel neurovascular solutions to market.

C2 Therapeutics, Inc. develops treatment for esophageal cancer. Its Coldplay CryoBalloon Focal Ablation System sets a new standard for simplicity in ablation of Barrett’s Esophagus. The company was founded by Peter Garcia-Meza in 2007 and is headquartered in Redwood City, CA.

Chestnut Medical Technologies, Inc. developed minimally-invasive therapies for interventional neuroradiology. Its portfolio of treatment options included: peripheral angioplasty balloons, stents, plaque excision systems, embolic protection devices, liquid embolics, embolization coils, thrombectomy catheters and occlusion balloons. Chestnut Medical Technologies was founded in 2000 and was headquarters in Menlo Park, CA.